Abstract
Inflammatory disorders such as rheumatoid arthritis (RA), may have profound effects on skeletal homeostasis. In contrast to physiologic remodeling in which mechanical influences and/or systemic endocrine hormones initiate the remodeling process, in disorders such as RA the recruitment of macrophage lineage cells to sites of inflammation and the action of local osteoclastogenic cytokines associated with the inflammatory process initiate the remodeling process. In both physiologic and pathologic remodeling, osteoclasts appear to be the principal cell type responsible for the bone resorption. In addition, many of the same cytokines and mediators are involved in physiologic and pathologic bone remodeling. These observations have important implications with respect to the development of therapeutic strategies to prevent bone loss in inflammatory conditions.
Similar content being viewed by others
References
DB Burr (2002) ArticleTitleTargeted and nontargeted remodeling. Bone 30 2–4 Occurrence Handle10.1016/S8756-3282(01)00619-6 Occurrence Handle1:STN:280:DC%2BD38%2FmvVWmsg%3D%3D Occurrence Handle11792556
AM Parfitt (2002) ArticleTitleTargeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30 5–7 Occurrence Handle10.1016/S8756-3282(01)00642-1 Occurrence Handle1:STN:280:DC%2BD38%2FmvVWksQ%3D%3D Occurrence Handle11792557
A Parfitt (2001) ArticleTitleTargeted and non-targeted bone remodeling: relationship to BMU origination and progression. Bone 30 585–587
RB Martin (2002) ArticleTitleIs all cortical bone remodeling initiated by microdamage? Bone 30 8–13 Occurrence Handle10.1016/S8756-3282(01)00620-2 Occurrence Handle1:STN:280:DC%2BD38%2FmvVWktA%3D%3D Occurrence Handle11792558
LC Hofbauer S Khosla CR Dunstan et al. (2000) ArticleTitleThe roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 2–12 Occurrence Handle1:CAS:528:DC%2BD3cXmsVygsQ%3D%3D Occurrence Handle10646108
T Suda N Takahashi N Udagawa et al. (1999) ArticleTitleModulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 345–357 Occurrence Handle10368775
S Teitelbaum (2000) ArticleTitleBone resorption by osteoclasts. Science 289 1504–1508 Occurrence Handle10.1126/science.289.5484.1504 Occurrence Handle10968780
SR Goldring EM Gravallese (2000) ArticleTitlePathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12 195–199 Occurrence Handle10.1097/00002281-200005000-00006 Occurrence Handle10803748
WS Simonet DL Lacey CR Dunstan et al. (1997) ArticleTitleOsteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 309–319 Occurrence Handle9108485
E Romas M Gillespie T Martin (2002) ArticleTitleInvolvement of receptor activator of NF-κβ ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30 340–346 Occurrence Handle10.1016/S8756-3282(01)00682-2 Occurrence Handle1:CAS:528:DC%2BD38Xhtleqsr8%3D Occurrence Handle11856640
H Kanzaki M Chiba Y Shimizu et al. (2002) ArticleTitlePeriodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via PGE2 synthesis. J Bone Miner Res 17 210–220 Occurrence Handle1:CAS:528:DC%2BD38XhtVymtbY%3D Occurrence Handle11811551
T Bateman C Dunstan V Ferguson et al. (2000) ArticleTitleOsteoprotegerin mitigates tail suspension-induced osteopenia. Bone 26 443–449 Occurrence Handle1:CAS:528:DC%2BD3cXisFGruro%3D Occurrence Handle10773583
Y Kobayashi F Hashimoto H Miyamoto et al. (2000) ArticleTitleForce-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. J Bone Miner Res 15 1924–1934 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCltbc%3D Occurrence Handle11028444
SR Goldring EM Gravallese (2000) ArticleTitleMechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2 33–37 Occurrence Handle10.1186/ar67 Occurrence Handle1:STN:280:DC%2BD3M7lsVOmug%3D%3D Occurrence Handle11094416
EM Gravallese C Manning A Tsay et al. (2000) ArticleTitleSynovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43 250–258 Occurrence Handle1:STN:280:DC%2BD3c7lsFGgsg%3D%3D Occurrence Handle10693863
DR Haynes TN Crotti M Loric et al. (2001) ArticleTitleOsteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40 623–630 Occurrence Handle10.1093/rheumatology/40.6.623 Occurrence Handle1:CAS:528:DC%2BD3MXlsFSiu70%3D
T Kuratani K Nagata T Kukita et al. (1998) ArticleTitleInduction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol 13 751–759 Occurrence Handle1:STN:280:DyaK1czlsVGqsg%3D%3D Occurrence Handle9690133
E Romas O Bakharevski DK Hards et al. (2000) ArticleTitleExpression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 43 821–826 Occurrence Handle10765926
Y Suzuki F Nishikaku M Nakatuka et al. (1998) ArticleTitleOsteoclast-like cells in murine collagen-induced arthritis. J Rheumatol 25 1154–1160 Occurrence Handle1:CAS:528:DyaK1cXjvVemtr4%3D Occurrence Handle9632079
Y Fujikawa M Shingu T Torisu et al. (1996) ArticleTitleBone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 35 213–217 Occurrence Handle1:STN:280:BymC1Mvhslw%3D Occurrence Handle8620294
JS Chang JM Quinn A Demaziere et al. (1992) ArticleTitleBone resorption by cells isolated from rheumatoid synovium. Ann Rheum Dis 51 223–1229
Y Suzuki Y Tsutsumi M Nakagawa et al. (2001) ArticleTitleOsteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium. Rheumatology (Oxford) 40 673–682 Occurrence Handle10.1093/rheumatology/40.6.673 Occurrence Handle1:CAS:528:DC%2BD3MXlsFSiu7k%3D
A Pettit J Hong D von Stechow et al. (2001) ArticleTitleTRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159 1689–1699 Occurrence Handle1:STN:280:DC%2BD3Mnltl2rsA%3D%3D Occurrence Handle11696430
K Redlich S Hayer A Maier et al. (2002) ArticleTitleTumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46 785–792 Occurrence Handle10.1002/art.10097 Occurrence Handle1:CAS:528:DC%2BD38XisFOmtL0%3D Occurrence Handle11920416
YY Kong U Feige I Sarosi et al. (1999) ArticleTitleActivated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 304–309 Occurrence Handle10580503
NJ Horwood V Kartsogiannis JMW Quinn et al. (1999) ArticleTitleActivated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265 144–150 Occurrence Handle10.1006/bbrc.1999.1623 Occurrence Handle10548505
H Takayanagi H Iizuka T Juji et al. (2000) ArticleTitleInvolvement of receptor activator of nuclear factor kappa-β ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43 259–269 Occurrence Handle1:CAS:528:DC%2BD3cXhs1aqtLw%3D Occurrence Handle10693864
M Tsuboi A Kawakami T Nakashima et al. (1999) ArticleTitleTumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134 190–191 Occurrence Handle10482302
S Chen D Guttridge E Tang et al. (2001) ArticleTitleSuppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaβ-independent bone morphogenetic protein/Smad signaling. J Biol Chem 276 39259–39263 Occurrence Handle10.1074/jbc.M105335200 Occurrence Handle1:CAS:528:DC%2BD3MXnvVemsbw%3D Occurrence Handle11500509
S Shimizu S Shiozawa K Shiozawa et al. (1985) ArticleTitleQuantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 28 25–31 Occurrence Handle1:STN:280:BiqD1Mjht1Y%3D Occurrence Handle3966938
M Bromley DE Woolley (1984) ArticleTitleHistopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 27 857–863 Occurrence Handle6466394
SR Goldring (1996) Osteoporosis and rheumatic diseases. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed. Lippincott-Raven Philadelphia 299–301
SR Goldring RP Polisson (1998) Bone disease in rheumatological disorders. L Avioli SM Krane (Eds) Metabolic bone disease, 2nd ed. Academic Press San Diego 621–635
K Saag K Rochelle J Caldwell et al. (1994) ArticleTitleLow-dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96 115–123 Occurrence Handle1:STN:280:ByuC2M3ms1M%3D Occurrence Handle8109596
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goldring, S. Inflammatory Mediators as Essential Elements in Bone Remodeling . Calcif Tissue Int 73, 97–100 (2003). https://doi.org/10.1007/s00223-002-1049-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-1049-y